Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.45% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
SIGA Technologies
SIGA
$222M
| $12.8M | ﹤0.01% |
2,126,065
+217,926
| +11% | +$1.46M |
|
2202
Richardson Electronics
RELL
$251M
| $12.8M | ﹤0.01% |
910,085
-9,766
| -1% | -$135K |
|
2203
Limoneira
LMNR
$227M
| $12.8M | ﹤0.01% |
521,638
+11,304
| +2% | +$302K |
|
2204
Axogen
AXGN
$2.71B
| $12.7M | ﹤0.01% |
772,752
+91,984
| +14% | +$1.3M |
|
2205
Hain Celestial
HAIN
$51.9M
| $12.7M | ﹤0.01% |
2,067,866
+412,658
| +25% | +$3.3M |
|
2206
XPEL
XPEL
$1.26B
| $12.7M | ﹤0.01% |
317,971
+3,701
| +1% | +$158K |
|
2207
Descartes Systems
DSGX
$6.78B
| $12.7M | ﹤0.01% |
111,643
+2,839
| +3% | +$317K |
|
2208
American Outdoor Brands
AOUT
$195M
| $12.6M | ﹤0.01% |
826,168
-10,018
| -1% | -$108K |
|
2209
Quad
QUAD
$501M
| $12.6M | ﹤0.01% |
1,805,081
-331,826
| -16% | -$2.25M |
|
|
ONT
2210
Onterris Inc
ONT
$620M
| $12.6M | ﹤0.01% |
677,218
+143,653
| +27% | +$3.02M |
|
2211
Nature's Sunshine
NATR
$231M
| $12.6M | ﹤0.01% |
856,701
+30,464
| +4% | +$446K |
|
2212
ScottsMiracle-Gro
SMG
$3.2B
| $12.5M | ﹤0.01% |
189,198
+160,225
| +553% | +$12.7M |
|
2213
First Bank
FRBA
$444M
| $12.5M | ﹤0.01% |
890,493
+23,012
| +3% | +$337K |
|
2214
Rocky Brands
RCKY
$328M
| $12.5M | ﹤0.01% |
549,171
-2,785
| -0.5% | -$68.1K |
|
2215
iRadimed
IRMD
$1.06B
| $12.5M | ﹤0.01% |
227,257
+7,606
| +3% | +$400K |
|
|
AKRO
2216
DELISTED
Akero Therapeutics
AKRO
| $12.5M | ﹤0.01% |
449,110
+442,014
| +6,229% | +$13.4M |
|
2217
NACCO Industries
NC
$293M
| $12.5M | ﹤0.01% |
418,006
-12,274
| -3% | -$364K |
|
2218
Opendoor
OPEN
$2.51B
| $12.4M | ﹤0.01% |
8,038,463
-5,593,597
| -41% | -$10.1M |
|
2219
Kura Oncology
KURA
$1.03B
| $12.4M | ﹤0.01% |
1,425,960
+372,196
| +35% | +$5.36M |
|
2220
Petco
WOOF
$693M
| $12.4M | ﹤0.01% |
3,242,546
+2,365,654
| +270% | +$10.7M |
|
|
DHIL
2221
DELISTED
Diamond Hill
DHIL
| $12.4M | ﹤0.01% |
79,638
+532
| +0.7% | +$85.2K |
|
2222
RxSight
RXST
$223M
| $12.3M | ﹤0.01% |
359,144
+237,877
| +196% | +$10.7M |
|
2223
Varonis Systems
VRNS
$5.44B
| $12.3M | ﹤0.01% |
276,682
-79,791
| -22% | -$4.15M |
|
2224
Relay Therapeutics
RLAY
$4.19B
| $12.2M | ﹤0.01% |
2,964,997
+1,216,334
| +70% | +$6.62M |
|
2225
ARKO Corp
ARKO
$489M
| $12.2M | ﹤0.01% |
1,851,140
+202,576
| +12% | +$1.4M |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.